Bio - NCH Healthcare System

Naples Heart Institute
399 Ninth Street N
Naples, FL 34102
(239)436-5634
(239) 261-1714 (FAX)
MEDICAL EDUCATION:
MICHAEL SCOTT FLYNN, M.D., F.A.C.C., F.S.C.A.I.
November 2011
1992-94 Interventional Cardiology Fellowship
Division of Cardiology
Saint Louis University Health Sciences Center
1989-92 Cardiovascular Diseases Residency
Division of Cardiology
St. Louis University
o Chief Cardiology Resident 1990-91
o Resident of the Year 1991
1987-89 Internal Medicine Residency
Department of Internal Medicine
St. Louis University and John Cochran Veterans Administration Hospital
St. Louis, MO
o Chief Internal Medicine Resident 1988-89
1986-87 Internship - Internal Medicine
St. Louis University Hospital
1982-86 St. Louis University School of Medicine
St. Louis, MO
o Degree:Doctor of Medicine - 1986
o Merck, Mosby and Lange Book Award
EDUCATION
1978-82 Miami University
Oxford, OH
o Evans Scholarship (4 years, Full tuition)
o Degree: Bachelor of Arts Chemistry
1

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
EMPLOYMENT
3/1/10-Present Naples Heart Institute (NCHMD)
2/2/07-3/1/10 Naples Cardiovascular Specialists Group Practice
7/1/94-2/1/07 Gulfcoast Cardiology, Private Practice
Michael S. Flynn, M.D., F.A.C.C., F.S.C.A.I., P.A.
606 Ninth Street North, Suite 100
Naples, FL 34102
Staff Privileges
o Naples Community Hospital and North Collier Hospital (1994) Active Staff
Chief, Division of Cardiology, 1996-1998
Chairman, Invasive Cardiology Committee, 1998 - 2000
Member:
Physician Excellence Committee (PEC) 2011-
- Department of Internal Medicine
- Critical Care Committee: 2010-
- CME Committee (1994-98)
- Invasive Cardiology Committee
- Physiologic Monitoring Committee
- Cardiovascular Executive Task Force
- Professional Capabilities Committee (2000-2005)
- Code Save A Heart Committee (2000-)
- Medical Staff/Nursing Liason Committee (2004-)
o Lee Memorial Hospital (Healthpark) (1994-1996) Associate Staff
o Southwest Florida Regional Medical Center (1995) Associate Staff
3/26/08- Clinical Assistant Professor of PA-C Program
Nova Southeastern University
Naples, Florida
1992-7/1/94 Assistant Professor of Medicine
Associate Director, Coronary Care Unit, Division of Cardiology
Saint Louis University Health Sciences Center
o Member, St. Louis University Hospital Medical Staff 1992-1994
o Member, Special Care Review Committee 1993-1994
o Member, Medical Staff (Provisional Courtesy)
Memorial Hospital of Carbondale
404 W. Main Street, P.O. Box 10,000
Carbondale, IL 6 2902-9000
Herrin Hospital
201 S. 14th Street
Herrin, IL 62948
2

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
MEDICAL LICENSURE
Florida - Professional Registration: ME 0065562 1994 - Present
DEA: BF1425722
CSN: 42065
BOARD CERTIFICATION
2011 Recertification, ABIM - Cardiovascular Disease
2009 Maintenance of Certification Program – Cardiovascular Disease
2008 Recertification, ABIM, - added qualification Interventional Cardiology
2000 Diplomate, American Board of Internal Medicine, Cardiovascular Diseases 124730 Recertification
1999 Diplomate, American Board of Internal Medicine, Added Qualification: Interventional Cardiology
1991 Diplomate, American Board of Internal Medicine, Cardiovascular Diseases 124730
1989 Diplomate, American Board of Internal Medicine 124730
CERTIFICATION
1996 American College of Cardiology ECGEXAM
2002 IVUS Preceptorship Training Program
8/2004 Filterwire, EZ Embolic Protection System Training (NCH).
2006 ACLS
2/2006 Starclose Vascular Closure System (NCH)
11/2006 Advanced Treatment Strategies i n M anaging C hronic Occlusions. Baptist C ardiac a nd
Vascular Institute.
2007 ACLS
2008 ACLS
2009 ACLS
2011 ACLS
AWARD
2004 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2005 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2006 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2007 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2008 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2009 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2010 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
2011 America's Top Doctors (Southwest Florida) - Top Interventional Cardiologist
JOURNAL REVIEWER 1996 - 98
Cardiac Cath and CV Diagnosis
American Journal of Cardiology (2000 - )
Special R ecognition: National Register of Who's Who in E xecutives an d P rofessionals ( Millennium
Edition)
(2005-) Relevance Reviewer; ABIM: Interventional Cardiology Board Exam
3

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
PROFESSIONAL SOCIETIES
o Fellow, American College of Cardiology (1994)
o Member Echo Task Force, FCACC 2008
o Fellow, Society for Cardiac Angiography and Interventions (1994)
o Member, Collier County Medical Society (1994)
o Member, Florida Medical Association (1994)
o Mended Hearts, Inc. Lifetime Member
OTHER INTERESTS
o Member, Par Club, Western Golf Association (WGA) 1986 - Present
RESEARCH (1992-1994)
1. Kern MJ, Aguirre FV, Chaitman BR, Bach R, Donohue TJ, Flynn MS, Labovitz AJ, Miller LW. The
graft study (Graft Reperfusion After Thrombolysis): A randomized trial of urokinase and t-PA for
intragraft thrombus and myocardial ischemia: A multicenter trial.
2. Kern M J, Aguirre F V, Bach R , D onohue TJ, Wolford T, P enick D , Flynn MS, L abovitz AJ. A
double-blind parallel comparison of the effects of intravenous ranolazine versus placebo on indices
of ischemia in patients undergoing coronary angioplasty.
3. Kern MJ, Aguirre FV, Bach R, Donohue TJ, Flynn MS. Intracoronary stenting for acute occlusion
after coronary balloon angioplasty and as a primary treatment for coronary occlusive disease.
4. Cohen JC, Flynn MS, Loyet A. A randomized, placebo-controlled double-blind parallel study of the
safety and antihypertensive efficacy of losartan monotherapy as compared to HCTZ monotherapy
and the combination of losartan and HCTZ in patients with mild to moderate hypertension.
5. Cohen J C, Flynn MS. T he e ffect o f oral D -sotalol on m ortality in p atients with a therosclerotic
coronary heart disease and left ventricular dysfunction "SWORD."
6. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson
R, Dincer B, Serota H, Reese J, Mechem CJ, Stonner T, Cauley M, Abbott L. Velocity assessment
for lesions of indeterminate severity "VALID."
7. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson
R, D incer B , Serota H , R eese J , M echem C J, Stonner T, C auley M , Abbott L. A r andomized,
open-label, parallel study to evaluate the effects of fluosol on complications, duration of hospital
stay and l eft v entricular function i n coronary angioplasty p atients a t hi gh r isk of hemodynamic
deterioration.
8. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson
R, Dincer B, Serota H, Reese J, Mechem CJ, Stonner T, Cauley M, Abbott L. Simvastatin coronary
vasoreactivity trial.
9. Chaitman BR, Aguirre FV, Flynn MS, Kern M, Wiens RD, Labovitz AJ, Lewis L, Quick G, Chang L,
Brooks C , F ortney J , R uoff B, N aunheim R. Thrombolysis an d t hrombin i nhibition in ac ute
myocardial infarction - TIMI 9 (CGP 39393, IND #34046).
4

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
RESEARCH (1992-1994) – CONT’D
10. Bach RG, Kern MJ, Aguirre FV, Donohue TJ, Caracciolo EA, Wolford T, Flynn MS, Moore JA,
Al-Joundi B, J ohnson R, R eese J, D incer B. R andomized t rial of compliant v s no ncompliant
balloons in elective angioplasty.
11. Aguirre FV, Bach R, Caracciolo E, Chaitman BR, Donohue T, Flynn MS, Kern MJ, Miller L, Wiens
R, Wolford T. A multicenter randomized, double-blind study to compare the safety and efficacy of
fixed l ow do ses of coumadin plus aspirin t o aspirin alone i n the p revention of r einfarction,
cardiovascular death and stroke in post myocardial infarct patients (IRB #7292).
12. Kern MJ, Donohue T, Bach R, Caracciolo E, Wolford T, Flynn MS, Dincer B, Johnson R, Reese J,
Roth R, A guirre FV, S tonner T , Cauley M. A m ulticenter, do uble-blind, r andomized study t o
compare t he safety an d ef ficacy of B G8967 with h eparin in p atients with un stable a ngina
undergoing percutaneous transluminal coronary angioplasty.
13. Flynn MS, Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue T, Al-Joundi B, Moore JA,
Wolford T. Assessment of U SCI t apered balloon v s s tandard bal loon c oronary ang ioplasty:
examination of arterial endoluminal morphology and physiology.
14. Aguirre F V, Kern MJ, D onohue T , B ach RG, Caracciolo E , Wolford T , Flynn MS, Din cer B ,
Johnson R , R eese J , A l-Joundi B , Moore J . Unstable ang ina with t hrombosis pi lot s tudy of
intralesional t-PA use with angioplasty (UTOPIA).
15. Kern M J, Aguirre F V, Bach R G, D onohue T, C aracciolo E , Flynn MS, Wolford T , L abovitz A,
Al-Joundi B , M oore JA. Effect o f i ntra-aortic b alloon c ounterpulsation o n coronary bl ood flow
velocity in patients.
16. Kern MJ, Aguirre FV, Donohue TJ, Bach RG, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B,
Moore JA, Johnson R, Reese J, Dincer B. Doppler end-points balloon angioplasty trial Europe
(DEBATE) and ENDPT Trial USA.
17. Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue TJ, Wolford T, Flynn MS, Moore JA,
Al-Joundi B. Clinical investigation of the Leocor Corflo Select hemoperfusion/PTCA catheter.
18. Aguirre FV, K ern MJ, D onohue T J, B ach RG, Caracciolo E , Wolford T , Flynn MS, Dincer B ,
Johnson R , R eese J , Al-Joundi B, M oore J . A r andomized, dou ble-blind ef ficacy and s afety
evaluation of two dosing regimens of integrilin versus placebo for reducing the complications of
coronary angioplasty.
19. Aguirre FV, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS, Wolford T, Al-Joundi B, Moore J.
Coronary hemodynamic effects of intravenous amlodipine during myocardial ischemia in patients
with coronary artery disease.
20. Co-investigator: Clinical Pharmacology Investigations DSI Laboratories; ASSENT I Trial.
21. Principal investigator: OPUS - TIMI 16 Trial. 1999, Naples Florida
22. Co-Investigator: ASSENT II Trial.
5

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
RESEARCH (1992-1994) – CONT’D
23. Co-Investigator: Proves Assessing outcomes an d efficient d elivery o f rate responsive t herapy.
1998. A comparison of automatic rate profile optimization versus manual programming.
24. Flynn MS, Javier JJ, Boucek FC, Levine RL, Toggart EJ, Travalia SC, Venable JM, Tober RB,
Roesch K , O'Neill W: P ercutaneous C oronary R evascularization (PCR) i n Acute M yocardial
Infarction, in Naples, Florida, 1999.
25. Naples Community Hospital Co-Advocate: Crusade 2001-2002
PUBLICATIONS
1. Flynn MS, Light TL. A hole in (B) one. Orthopedics, Feb 1986, Vol. 9, No. 2, pp 289-291.
2. Stratmann H G, Flynn MS, Li ttlefield J L, Wittry M D. M yocardial i maging w ith technetium-99m
sestamibi after exercise induced ventricular tachycardia. Am Heart J 1992; 124:1374-1377.
3. Flynn MS, Kern MJ, D onohue T , B ach R . Management of a c omplicated p ericardiocentesis.
Cathet Cardiovasc Diagn 1992; 25:249-252.
4. Flynn MS, Castello R, McBride LW, Labovitz AJ. Ruptured congenital aneurysm of the sinus of
Valsalva w ith persistent l eft s uperior v ena cava i maged by i ntra-operative t ransesophageal
echocardiography. Am Heart J 1993; 125:1185-1187.
5. Flynn MS, Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA. Alterations of coronary
collateral blood flow velocity during intra-aortic balloon pumping in patients. Am J Cardiol 1993;
71:1451-1454.
6. Kern MJ, Wolford T, Donohue TJ, Bach RG, Aguirre FV, Caracciolo EA, Flynn MS. Quantitative
demonstration o f di pyridamole-induced coronary steal a nd al teration by ang ioplasty in m an:
analysis by simultaneous, continuous dual Doppler spectral flow velocity. Cathet Cardiovasc Diagn
1992; 29:329-334.
7. Flynn MS, A guirre F V, D onohue TJ, Bach RG, C aracciolo EA, K ern M J. C onservative
management of guidewire coronary artery perforation with pericardial effusion during angioplasty
for acute inferior myocardial infarction. Cathet Cardiovasc Diagn 1993; 29:285-288.
8. Flynn MS, Kern MJ, Aguirre FV, Caracciolo EA, Donohue TJ, Bach RG. Facilitated drainage of
pericardial effusion with a fenestrated pigtail catheter and sheath system. Cathet Cardiovasc Diagn
1993; 30:73-75.
9. Kern M J, Flynn MS, C aracciolo E A, Bach R G, Donohue T J, A guirre FV. Use of t ranslesional
coronary flow velocity for interventional decisions in a patient with multiple intermediately severe
coronary stenoses. Cathet Cardiovasc Diag 1993; 29:148-153.
10. Kern M J, Flynn MS, A guirre F V, D onohue TJ, B ach R G, C aracciolo E A. Application of
intracoronary flow velocity for detection and management of ostial saphenous vein graft lesions.
6

Cathet Cardiovasc Diag 1993; 30:5-10.
Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
PUBLICATIONS – CONT’D
11. Kern MJ, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS, Aguirre FV. Clinical applications of the
Doppler coronary flow velocity guidewire for interventional procedures. J Interven Cardiol 1993;
6(4):345-363.
12. Kern MJ, Aguirre FV, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS. Coronary flow velocity
monitoring after angioplasty associated with abrupt reocclusion. Am Heart J 1994; 127:436-438.
13. Flynn MS, Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue TJ. Interventional Physiology,
Part III: Alterations in coronary blood flow velocity during intracoronary thrombolysis and rescue
coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diag 1994; 31:219-224.
14. Kern MJ, Aguirre AV, Bach RG, Caracciolo EA, Donohue TJ, Flynn MS, Moore JA. Interventional
Physiology, Part IV: Alterations of coronary flow velocity distal to coronary dissections before and
after intracoronary stent placement. Cathet Cardiovasc Diag 1994; 31:309-315.
15. Flynn MS, Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue TJ. Interventional Physiology,
Part V: Intramyocardial muscle bridging of the coronary artery: an examination of a diastolic "spike
and dome" pattern of coronary flow velocity. Cathet Cardiovasc Diag 1994; 32:36-39.
16. Kern MJ, Donohue TJ, Flynn MS, Aguirre FV, Bach RG, Caracciolo EA. Interventional Physiology,
Part IX: Li mitations of t ranslesional pr essure and f low velocity f or long os tial left anterior
descending stenoses. Cathet Cardiovasc Diag 1994; 33:50-54.
17. Kern MJ, Aguirre FV, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS, Wolford T, Moore JA.
Continuous coronary flow velocity monitoring during coronary interventions: velocity trend patterns
associated with adverse events. AM Heart J 1994; 128:426-434.
18. Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA, Wolford T, Mechem C, Flynn MS,
Chaitman B. C linical outcome of d eferring angioplasty i n p atients w ith n ormal translesional
pressure and flow velocity measurements. J Am Coll Cardiol 1995; 25:178-187.
19. Flynn MS, C aracciolo E A, B ach R G, D onohue TJ, Aguirre F V, Kern M J. A pproach to t otal
occlusion of an aorto-ostial "Y" saphenous vein graft with anterior descending graft limb stenosis by
serial b alloon a ngioplasty a nd el ective s tent deployment. Cathet C ardiovasc D iag 1994;
33:139-144.
20. Al-Joundi B, Kern MJ, Aguirre FV, Donohue TJ, Moore JA, Flynn MS. Interventional Physiology,
Part X VIII: I nfluence o f i ntra-aortic ba lloon counterpulsation and c ollateral flow r eversal d uring
multivessel angioplasty. Cathet Cardiovasc Diag 1995; 35:149-158.
21. Shapiro MJ, Wittgen C, Flynn MS, Zuckerman DA, Durham RM, Mazuski JE. Right coronary artery
occlusion secondary to blunt trauma. Clin Cardiol 1994; 17:157-159.
22. Bach RG, Kern MJ, Donohue TJ, Wolford T, Moore JA, Flynn MS. Part XXI: Patterns of Phasic
7

Coronary Collateral Flow Velocity in Patients. Cathet Cardiovasc Diag 1995; 36: 134-142.
Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
PUBLICATIONS – CONT’D
23. Aguirre FV, Werth D, Gudipati C, Lewen MK, Pedersen WR, Johnson WB, Hamilton W, Gibson P,
Armbruster RW, S tonner T , Flynn MS, A l-Joundi B , Chaitman B R. Clinical an d Angiographic
Outcomes Among P atients R eceiving 2 4 v s 7 2 H ours of I ntravenous H eparin F ollowing
Accelerated Dosing of Recombinant Tissue Plasminogen Activator in Acute Myocardial Infarction.
Submitted to Circulation 7/5/96.
Books and Chapters
1. Kern MJ , Flynn MS. A pproach to t he assessment o f myocardial v iability i n the c ardiac
catheterization laboratory. In Iskandrian AS, van der Wall EE (eds): "Myocardial Viability: Detection
and Clinical Relevance," Kluwer Academic Pub, The Netherlands, 1993.
2. Kern M J, Flynn MS. Clinical applications of i ntracoronary c oronary D oppler flow v elocity i n
interventional cardiology. I n White C J ( ed): "Advances i n I nterventional C ardiology: New
Technologies and Strategies for Diagnosis and Treatment," Marcel Dekker, New York, NY, 1993.
3. Deligonul U, Ro th R, Flynn MS. A rterial and v enous access. I n Kern M J ( ed): "The C ardiac
Catheterization Handbook, 2nd edition." Mosby-Year Book, St. Louis, 1994.
ABSTRACTS
1. Aguirre FV, Werth D, Gudipati CV, Pedersen W, Lewen M, Wise NK, Changlani M, Al-Joundi B,
Flynn MS, Stonner T, K ern M J, C haitman B. F actors l imiting effective heparinization following
thrombolysis for acute myocardial infarction: interim findings from the t-PA-heparin duration trial. J
Am Coll Cardiol 1993; 21:136A.
2. Aguirre F , Werth D, Gudipati R , Gibson P , P edersen W, Johnson WB, Lewen M, Hamilton W,
Al-Joundi B, Flynn MS, Armbruster R, Stonner T, Chaitman B for t-PA heparin trial investigators.
Influence of intravenous heparin d uration o n c linical o utcome of p atients r eceiving a ccelerated
weight-adjusted r t-PA for ac ute myocardial i nfarction: pr eliminary r esults o f the multicenter
randomized t-PA heparin duration trial. Circulation 1993; 88(4):I-201.
3. Kern M J, D onohue T, B ach R , Aguirre F , Caracciolo E , M echem C, Cauley M , Flynn MS,
Chaitman B. Clinical outcome of deferred angioplasty in patients based on normal translesional
pressure-flow velocity measurements. Circulation 1993; 88(4):I-204.
4. Wolford R, Wolford T , A st M, Flynn MS, J ennison S , Cauley M , Miller LW. A ngiographic
appearance of coronary arteries f rom t ransplanted he arts pr edicts c oronary f low reserve.
Circulation 1993; 88(4):I-420.
5. Aguirre FV, Werth D, Gudipati, CV, Gibson P, Pedersen W, Lewen M, Serota H, Johnson W,
Armbruster R , A l-Joundi B , Flynn MS, S tonner T, N emeth N , Kern M J, C haitman B. Op timal
duration of heparinization following thrombolytic therapy for acute myocardial infarction: interim
results of the multicenter r andomized t -PA h eparin duration s tudy. X Vth C ongress European
8

Society Cardiol (Accepted). 1996.
Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
ABSTRACTS – CONT’D
6. Kern MJ, Anderson HV, Talley JD, Caracciolo EA, Bach RG, Donohue TJ, Aguirre FV, Moore JA,
Flynn MS, Segal J, Mechem CJ, Cauley M, Stikovac M. Relationship of post-procedural distal
coronary flow dynamics with restenosis after coronary angioplasty: results of a multicenter pilot
study. 43rd Scientific Sessions American College of Cardiology J Am Coll Cardiol 1994;
7. Moore JA, Kern MJ, Donohue TJ, Bach RG, Caracciolo EA, Aguirre FV, Flynn MS. Distal coronary
flow velocity and physiology during direct angioplasty for acute myocardial infarction in patients.
43rd Scientific Sessions American College of Cardiology J Am Coll Cardiol 1994; 23:243A.
8. Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue TJ, Moore JA, Flynn MS, Mechem CJ,
Cauley M , Labovitz A J. C omparison o f intralesional D oppler flow v elocity and q uantitative
angiography f or de termination o f translesional pr essure gradients in patients. 43rd S cientific
Sessions American College of Cardiology J Am Coll Cardiol 1994; 23:174A.
9. Bach RG, Kern MJ, Donohue TJ, Aguirre FV, Caracciolo EA, Flynn MS, Wolford T. Correlation of
intracoronary flow velocity with subsequent stent restenosis. Society for Cardiac Angiography &
Interventions, 17th Annual Meeting. Cathet Cardiovasc Diag 1994; 32:92.
10. Moore JA, Kern MJ, Donohue TJ, Bach RG, Caracciolo EA, Aguirre FV, Flynn MS. Disparity of
TIMI grade flow and directly measured coronary flow velocity during direct angioplasty for acute
myocardial i nfarction. Society f or C ardiac A ngiography & I nterventions, 17th A nnual M eeting.
Cathet Cardiovasc Diag 1994; 32:86.
11. Steven B H Timmis, G erald C . Timmis, M ark C . Pica, William B eaumont H ospital, Michael S.
Flynn, Ro bert B . Tober, N aples Co mmunity Ho spital, William W. O'Neill, William B eaumont
Hospital. F acilitated primary p ercutaneous i ntervention i n acute myocardial i nfarction using
glycoprotein IIB/IIIA inhibitors with or without thrombolytic therapy. AHA Scientific Sessions 2001,
November 11-14, 2001, Anaheim, California, Abstract ID 115616.
PRESENTATIONS
1. Flynn MS, Werth D, Gudipati R, Pedersen W, Serota H, Johnson WB, Gibson P, Hamilton W,
Morton D, Changlani M, Armbruster R, Stonner T, Al-Joundi B, Lewen M, Aguirre F for the rt-PA
heparin duration t rial investigators. Influence o f h eparin d uration on c oronary ang iographic
characteristics in patients receiving accelerated weight-adjusted rt-PA dosing for acute myocardial
infarction. A m Heart A ssociation 66th Scientific S ession, N ovember, 1 993, Circulation 1993;
88(4):I-201.
POSTER PRESENTATIONS
1. Timmis S B, T immis G C, Flynn MS, Pica MC, Dixon S R, T ober RB , O 'Neill WW. A djunctive
thrombolytic therapy with or without glycoprotein IIb/IIIa inhibition prior to percutaneous coronary
intervention in acute myocardial infarction. ACC 50th Annual Scientific Session, Orlando, Florida,
Tuesday, March 20, 2001. JACC 2001; 37, No. 2 (supplement A) 350A, 1186-78.
9

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
CONTINUING MEDICAL EDUCATION
1. 18th Annual Scientific Session Society for Cardiac Angiography. May 18-20, 1995 (17.5 hrs)
2. Melvin P. Judkins Imaging Symposium. May 16-17, 1995 (13.5 hrs)
3. 1995-1996 Physician Update: Domestic Violence. September 20, 1995 (1 hr)
4. Update on AIDS. May 20, 1995 (2 hrs)
5. Risk Management. October 21, 1995 (5 hrs)
6. Interventional Cardiology XXX. Orlando, Florida. March 21-23, 1996 (25 hrs)
7. 45th Annual Scientific Session. American College of Cardiology. Orlando, Florida. March 24-27, 1996
(17.5 hrs)
8. Palmaz-Schatz Balloon Expandable Stent Coronary Certification Course. March 23, 1996. Orlando,
Florida
9. Symposium on Cardiology for the Primary Care Physician. 3/96 NCH.
10. 1997 Physicians update: Domestic Violence
11. 20th Annual Scientific Session Society for Cardiac Angiography 5/15-5/17/97 (12-1/2 hrs)
12. American Society of Echocardiography. Orlando, Florida. June 18-20, 1997 (15 hrs).
13. Rotablator Course, 1997.
14. New Directions, Orlando, Florida, November 1997.
15. Intervent 1998, Orlando, Florida, November 1997.
16. ACS M ulti-Link C oronary S tent System, P hysicians C ourse, O mni R osen H otel, O rlando, F lorida,
November 12, 1997, four hours.
17. Heart Failure, Society of America, Boca Raton, Florida, September 13-16, 1998
18. ACC/SCA&I Board R eview P rogram, Interventional C ardiology, A tlanta, G eorgia, O ctober 1 4-17,
1999
19. Board R eview C ourse - The O riginal 2000 Philadelphia Board R eview C ourse i n C ardiovascular
Disease, October 14-18, 2000.
20. ACC 50th Annual Scientific Session, Orlando, Florida, March 18-21, 2001.
21. CardioQuest 21st C entury: O ptimizing Treatment Outcomes i n Ischemic C oronary S yndromes
-Current Management of AMI: Evidence for Combination Therapy and Facilitated PCI, Ft. Lauderdale,
Florida, July 2001.
22. Gusto V results, Orlando, Florida, June 2001.
23. Risk Management Rounds: Physicians June 1, 2002 (7.5 hours), Medical Risk Management, Inc.
24. The I ntravascular R adiotherapy O nline Training P rogram, J uly 2 4, 2002, ( 4 h ours, C ategory 1) ,
Medical Media Communications, Inc.
25. Advanced Cardiovascular Interventions, June 16-20, 2003 (20 hours).
26. AHA, November 2003.
27. Florida ACC Annual Symposium, Bal Harbor, Florida, September 17019, 2004 (13.25 hours)
28. Evidence-Based Guidelines, October 20, 2004, NCH Healthcare System (1.5 hours)
29. American College of Cardiology Meeting, Orlando, Florida, March 7-8, 2005 (0.5 hours)
30. Adult Immunization for the 21 st Century’s Infectious. St. Louis University, St. Louis, MO 10/20/06 (3.5
hours).
31. SCAI – 30 th Annual Scientific Sessions 5/9/07 – 5/11/07 (18 CME).
32. Driving Competence – 5/23/07 – NCH (1 CME).
33. Prevention of Medical Errors – 6/9/07 NCH.
Domestic Violence (3.0 CME).
10

34. Advancements in Cardiac CT and Cardiovascular Imaging – 10/16/07 (2.5 CME).
35. GI Symposium – 10/25/07 – (3 CME).
Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
CONTINUING MEDICAL EDUCATION – CONT’D)
36. Cardiovillage – 8/29/07 (16 CME).
37. Computerized Physician Order Entry – 8/29/08 (2 CME).
38. ASE 3 rd Annual The Beat Goes On – 9/25/08 – 9/28/08 (25 CME).
39. GI Symposium – 10/22/08 – (2 CME).
40. Anticoagulation Update – 1/12/09 (1 CME).
41. Essential Echocardiography with Experts Featuring 3-D – 3/28/09 (7 CME).
42. Interventional Cardiology Simulations – 5/29/09 (1 CME).,
43. Domestic Violence – 6/6/09 (1 CME).
Prevention of Medical Errors (2 CME).
44. Hypertensive Module – 7/1/09 (20 CME).
45. GI Update – Making it Simple – 10/21/09 (2 CME).
LECTURES
1. Congestive Heart Failure. Healthcare Personnel. 1994
2. Treatment of Acute Myocardial Infarction. North Collier Hospital. November 29, 1995 (1 CME)
3. PTCA and C ardiovascular D isease. N aples C ommunity H ospital Auxiliary. N aples C ommunity
Hospital. February 12, 1996
4. Treatment of Acute Myocardial Infarction. Naples Community Hospital March 6, 1996
Symposium on Cardiology for the Primary Care Physician.
5. Moderator - Symposium: Issues i n C ardiovascular C are. N aples Community H ospital and P fizer
Sponsored (3 CME) Bonita Springs, FL 9/21/96.
6. Congestive Heart Failure Clinical Pathway. Naples Community Hospital, April 15, 1997.
7. Acute MI Nurses CV Symposium, 1998, Naples, Florida.
8. Invisible Coronary Plaque; Mended Hearts Meeting, NCH Healthcare System, June 14, 1999.
9. Code: Save-A-Heart, Collier County Leadership Group.
10. Up-to-Date Antiplatelet/Fibrinolytic Therapy for Acute M I. N CH/North C ollier E mergency R oom
Physicians, Centocor Sponsored, November 1999.
11. Direct Infarct Angioplasty, Greater Naples Leadership Masters Class Health Care Day – 1/17/01.
12. Infarct Odyssey 2001, Naples Community Hospital Emergency Room Physicians, August 2001.
13. Current Management of AMI: Evidence for Combination Therapy and Facilitated PCI, The Breakers,
Port Charlotte, Florida, 10/18/2001.
14. Direct Infarct Angioplasty: Bay Pines VA Hospital staff, St. Petersburg, Florida, 3/26/03.
15. Congestive Heart Failure Treatment, Naples Healthcare System, 8/14/04.
11

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
TELEVISION INTERVIEWS - The Medical Journal with Carl Loveday - MediaOne
1. February 14, 1997 - Coronary artery bypass, Brian Hummel, M.D.
2. February 14, 1998 - Coronary artery bypass and aortic valve surgery, Dennis Stapleton, M.D.
3. February 19, 1999 - Cardiology: Peripheral vascular surgery, Cristina Sciavolino, M.D.
4. February 11, 2000 - Save-A-Heart direct angioplasty.
5. August 29 , 200 0 - Save-A-Heart direct a ngioplasty, William O 'Neill, M .D., D irector of C ardiology,
William Beaumont Hospital, Royal Oak, Michigan
12